MUMBAI, India, July 25 -- Intellectual Property India has published a patent application (202421003607 A) filed by Intas Pharmaceuticals Ltd., Ahmedabad, Gujarat, on Jan. 18, 2024, for 'method for modulation of daratumumab glycosylation profile.'
Inventor(s) include Laxmi Adhikary; Velu Mahalingam; Viki Chopda; Dhananajay Kumar; Shreya Shah; Aadesh Dhamdhere; Swapnali Patekar; and Deeksha D Saripalla.
The application for the patent was published on July 25, under issue no. 30/2025.
According to the abstract released by the Intellectual Property India: "The present invention provides a method for modulation of galactosylation and mannosylation level of Daratumumab by supplementation of manganese chloride and modulation of afucosylation level of Daratumumab by maintaining pCO2 with pH of cell culture."
Disclaimer: Curated by HT Syndication.
